NCT04032678View on ClinicalTrials.gov

Comparison of Efficacy and Safety of Two Biphasic Defibrillators in Cardioversion of Atrial Fibrillation

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 5, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

August 6, 2020

Conditions

Atrial FibrillationArrythmiaElectric Countershock

Interventions

DEVICE

Schiller Defigard Touch 7 - DGT7, Schiller Medical, France

Cardioversion with a pulsed biphasic waveform

DEVICE

LIFEPAK 15, Physio-Control Inc., Redmond, WA, USA

Cardioversion with a biphasic truncated exponential waveform

Trial Locations (1)

1309

University National Heart Hospital, Sofia

All Listed Sponsors

lead

University National Heart Hospital

OTHER

NCT04032678 - Comparison of Efficacy and Safety of Two Biphasic Defibrillators in Cardioversion of Atrial Fibrillation | Biotech Hunter | Biotech Hunter